Germany· DE-A57-f5064dee291c55d3
Venoruton
A medicinal product containing o-(ß-hydroxyethyl)rutosides, registered in Germany by Stada Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- O-(ß-Hydroxyethyl)rutosides
- Manufacturer
- Stada Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
O-(ß-hydroxyethyl)rutosides in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandPosorutinURSAPHARM Poland Sp. z o.o.
- FranceRHEOFLUX 3500 mg, poudre pour solution buvable en sachet-doseETHYX PHARMACEUTICALS
- SpainESBERIVEN 100 mg/ml SOLUCION ORALFaes Farma S.A.
- BelgiumTroxerutine Mylan 300 mgViatris GX
- CzechiaCILKANOLZentiva, k.s., Praha
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Venoruton, Venoruton - Gel
- Belgium · Venoruton, Venoruton Beutel
- Bulgaria · Троксевазин, Троксерутин Абр
- Czechia · Cilkanol, Venoruton
- Denmark · Venoruton
- Estonia · Troxevasin, Troxevasin Teva
- Spain · Esberiven, Troxerutina Cinfalab
- France · Rheoflux, Veinamitol
- United Kingdom (Northern Ireland) · Paroven
- Greece · Venoruton
- Hungary · Venoruton
- Italy · Venolen, Venoruton
- Lithuania · Troxevasin, Venoruton
- Luxembourg · O-(B-Hydroxyaethyl)-Rutosidea Eg (Eurogenerics) Sa, O-(B-Hydroxyethyl)-Rutosidea Eg (Eurogenerics) Sa
- Latvia · Troxerutin Sopharma, Troxevasin
- Netherlands · Venoruton
- Poland · Posorutin, Rutoven
- Portugal · Venoruton
- Romania · Devaricid Gel, Troxerutin Chirmis
- Slovakia · Cilkanol, Venoruton
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cf363eef-e343-4258-8b67-880544a8ac37 GET /v1/drugs/cf363eef-e343-4258-8b67-880544a8ac37?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "O-(ß-Hydroxyethyl)rutosides",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about o-(ß-hydroxyethyl)rutosides.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.